跳至主要内容
临床试验/ACTRN12619000009112
ACTRN12619000009112尚未招募未知

Anxiety disorders in children with cystic fibrosis and their families: An exploration of the problem and proof-of-concept trial of the Fear-less Triple P intervention

Hayley Kimball0 个研究点目标入组 20 人开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 14 Years(—)
性别
All

入选标准

  • Inclusion criteria include: Children with Cystic Fibrosis and their parents/caregivers. Children must be aged between 6 years and 14 years inclusive. Children and their parents/caregivers must not be severely intellectually impaired and therefore unable to complete the measures; and must be able to read and write English fluently to complete the measures. Finally, parents/caregivers must be of the belief that their child would benefit from learning how to manage anxiety more effectively to participate. Families will not be excluded if their child does not meet criteria for an anxiety diagnosis as we wish to be as inclusive as possible in the piloting stage.

排除标准

  • Exclusion criteria include: Children who do not have Cystic Fibrosis. Patients aged <6 years or >14 years; those who are severely intellectually impaired and therefore unable to complete the measures; and those who cannot read or write English fluently and therefore are unable to complete the measures.

研究者

发起方
Hayley Kimball

相似试验